Page 1689 - Veterinary Immunology, 10th Edition
P. 1689

essential (core), 275
  VetBooks.ir     failure, 278–280, 278f



                  genetically engineered, 265–267

                  helminth, 321–322

                  immunosuppressive, 282–283, 308


                  inactivated, 264–265

                  intranasal, 246

                  killed, 264, 264t

                  live, 264, 267–268

                  modified live, 246


                  multiple antigens, 275–276

                  optional (non-core) vaccines, 275

                  oral, 246

                  polynucleotide, 268–270

                  polyvalent, 293–294

                  predictive, 277–278


                  production, 283–284

                  production enhancing, 414

                  prophylactic, 277

                  protozoa, 315

                  reactive, 277

                  recombinant, 276–277


                  ring, 277–278

                  schedules, 259, 276–277

                  strategies, 277–278

                  surfaces, 246

                  yeast-based, 268






                                                        1689
   1684   1685   1686   1687   1688   1689   1690   1691   1692   1693   1694